FVIII∶C was measured by a one-stage clotting assay and expressed as percent of normal pooled plasma (NPP). Fibrin density and platelet aggregate size were measured at the end of a 5 min. flow assay on
Values of Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen (FIB) in intraosseous (IO) and venous (IV) samples and differences (D) at first (1) and second (2) sampling
Measurements Study Description Bleeding and thrombosis represent major adverse events during extracorporeal membrane oxygenation (ECMO). Complications resulting from these events can lead to death or
